Ortoma AB Series B (ORT-B) - Total Liabilities
Based on the latest financial reports, Ortoma AB Series B (ORT-B) has total liabilities worth Skr18.63 Million SEK (≈ $2.00 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of Ortoma AB Series B to measure how many days the company can operate on defensive assets alone.
Ortoma AB Series B - Total Liabilities Trend (2021–2025)
This chart illustrates how Ortoma AB Series B's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Ortoma AB Series B to measure how efficiently the company converts operating cash flow to free cash.
Ortoma AB Series B Competitors by Total Liabilities
The table below lists competitors of Ortoma AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DynaCERT Inc.
TO:DYA
|
Canada | CA$5.89 Million |
|
Yong Shun Chemical Co Ltd
TWO:4711
|
Taiwan | NT$231.40 Million |
|
Medical Developments International Ltd
AU:MVP
|
Australia | AU$11.29 Million |
|
Micro-X Ltd
AU:MX1
|
Australia | AU$11.82 Million |
|
Fortune Bay Corp
V:FOR
|
Canada | CA$3.95 Million |
|
Big 5 Sporting Goods Corporation
NASDAQ:BGFV
|
USA | $482.30 Million |
|
Jembo Cable Company Tbk
JK:JECC
|
Indonesia | Rp1.66 Trillion |
|
MedMira Inc
V:MIR
|
Canada | CA$27.92 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Ortoma AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Ortoma AB Series B (ORT-B) total assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ortoma AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ortoma AB Series B (2021–2025)
The table below shows the annual total liabilities of Ortoma AB Series B from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr18.63 Million ≈ $2.00 Million |
-2.35% |
| 2024-12-31 | Skr19.07 Million ≈ $2.05 Million |
+1.48% |
| 2023-12-31 | Skr18.80 Million ≈ $2.02 Million |
-49.23% |
| 2022-12-31 | Skr37.02 Million ≈ $3.98 Million |
+836.96% |
| 2021-12-31 | Skr3.95 Million ≈ $425.22K |
-- |
About Ortoma AB Series B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more